Investment & licensing

We have expertise and developed technologies that have the potential to be transferred to industry and become a source of competitive advantage.

On this page

Investment in commercial technologies

Victoria University (VU) has knowledge and experience in ten specialised areas of research focus, which have commercial applications across a number of industry sectors in Australia and overseas.

If you are an investor, or would like to assist in the development of our technologies to expand your organisation, contact us to find out about:

  • licensing opportunities
  • Victoria University spin-out companies.

Current technologies

We are currently seeking expressions of interest for investment capital or licensing of technologies in the following areas:

Clean Green Ephedrine

Led by Associate Professors Andrew Smallridge and Maurice Trewhella, the chemistry research team at VU has developed a novel, green two-stage process for ephedrine manufacture utilising supercritical carbon dioxide, with potential applications across a broad range of industries. The new process uses less energy, produces less waste and is expected to be substantially cheaper than existing manufacturing processes.

A Membrane Distillation System

Researchers at VU’s Institute for Sustainability and Innovation, led by Associate Prof Mikel Duke, have developed a new membrane distillation system.

This new and innovative system integrates membrane distillation with conventional process heat-exchange. The key to the new system is that the heat energy source used to treat the stream by membrane distillation can be further utilised in the plant.

Contact us

For further information about current technologies or the commercial application of our research focus areas, please contact the Knowledge Exchange team.

Disclaimer: While all reasonable endeavours have been made in the preparation of information regarding the technologies described above, Victoria University does not warrant that the information is accurate or complete. Commercial partners are encouraged to undertake their own due diligence and make their own assessment regarding specific technologies. Information contained on this site is not, nor is it intended to represent the provision of financial product advice.